Page last updated: 2024-10-31

midazolam and Weight Gain

midazolam has been researched along with Weight Gain in 1 studies

Midazolam: A short-acting hypnotic-sedative drug with anxiolytic and amnestic properties. It is used in dentistry, cardiac surgery, endoscopic procedures, as preanesthetic medication, and as an adjunct to local anesthesia. The short duration and cardiorespiratory stability makes it useful in poor-risk, elderly, and cardiac patients. It is water-soluble at pH less than 4 and lipid-soluble at physiological pH.
midazolam : An imidazobenzodiazepine that is 4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted by a methyl, 2-fluorophenyl and chloro groups at positions 1, 6 and 8, respectively.

Weight Gain: Increase in BODY WEIGHT over existing weight.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bass, JY1
Caravella, JA1
Chen, L1
Creech, KL1
Deaton, DN1
Madauss, KP1
Marr, HB1
McFadyen, RB1
Miller, AB1
Mills, WY1
Navas, F1
Parks, DJ1
Smalley, TL1
Spearing, PK1
Todd, D1
Williams, SP1
Wisely, GB1

Other Studies

1 other study available for midazolam and Weight Gain

ArticleYear
Conformationally constrained farnesoid X receptor (FXR) agonists: heteroaryl replacements of the naphthalene.
    Bioorganic & medicinal chemistry letters, 2011, Feb-15, Volume: 21, Issue:4

    Topics: Animals; Binding Sites; Blood Glucose; Crystallography, X-Ray; Diabetes Mellitus, Experimental; Dogs

2011